Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents

The survival of multiple myeloma patients has improved significantly over the last several decades. However, the median overall survival of these patients remains less than 5 years. In this report, we discuss 4 cases of multiple myeloma patients that showed long survival. Interestingly, these patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Formato: Artigo
Idioma:Inglês
Publicado em: Karger Publishers 2017-10-01
Colecção:Case Reports in Oncology
Assuntos:
Indolent
Symptomatic myeloma
Conventional therapy
Absence of deep response
Acesso em linha:https://www.karger.com/Article/FullText/481166
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados